Pathology of tuberculosis: How the pathology of human tuberculosis informs and directs animal models

Microbiology Spectrum

Volumn 5, Issue 3, 2017, Pages

  Basaraba, Randall J ^a   Hunter, Robert L ^b  

^a Veterinary Dentistry and Oral Surgery   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE; TUBERCULOSTATIC AGENT;

ANIMAL; DISEASE EXACERBATION; DISEASE MODEL; DRUG EFFECTS; HOST PATHOGEN INTERACTION; HUMAN; LUNG; LUNG TUBERCULOSIS; MICROBIOLOGY; MYCOBACTERIUM TUBERCULOSIS; PATHOGENICITY; PATHOLOGY; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HOST-PATHOGEN INTERACTIONS; HUMANS; LUNG; MYCOBACTERIUM TUBERCULOSIS; TUBERCULOSIS; TUBERCULOSIS VACCINES; TUBERCULOSIS, PULMONARY;

EID: 85020244849     PISSN: None     EISSN: 21650497     Source Type: Journal    
DOI: 10.1128/microbiolspec.TBTB2-0029-2016     Document Type: Article

References (71)

1. Nuermberger EL, Yoshimatsu T, Tyagi S, Bishai WR, Grosset JH. 2004 Paucibacillary tuberculosis in mice after prior aerosol immunization with Mycobacterium bovis BCG. Infect Immun 72:1065-1071 http://dx.doi.org/10.1128/IAI.72.2.1065-1071.2004.
2. Dannenberg AM Jr. 2006. Pathogenesis of Human Pulmonary Tuberculosis: Insights from the Rabbit Model, p 453. ASM Press, Washington, DC.
3. Hunter RL. 2011. Pathology of post primary tuberculosis of the lung: an illustrated critical review. Tuberculosis (Edinb) 91:497-509 http://dx.doi.org/10.1016/j.tube.2011.03.007.
4. Hunter RL, Actor JK, Hwang SA, Karev V, Jagannath C. 2014. Pathogenesis of post primary tuberculosis: immunity and hypersensitivity in the development of cavities. Ann Clin Lab Sci 44:365-387.
5. Hunter RL, Jagannath C, Actor JK. 2007. Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs. Tuberculosis (Edinb) 87:267-278 http://dx.doi.org/10.1016/j.tube.2006.11.003.
6. Hunter RL. 2016. Tuberculosis as a three-act play: a new paradigm for the pathogenesis of pulmonary tuberculosis. Tuberculosis (Edinb) 97:8-17 http://dx.doi.org/10.1016/j.tube.2015.11.010.
7. Laennec R. 1821. A Treatise on Diseases of the Chest in Which They Are Described According to Their Anatomical Characters, and Their Diagnosis Established on a New Principle by Means of Acoustick Instruments, p 437. T&G Underwood, London, United Kingdom (reprinted 1979 by The Classics of Medicine Library, Birmingham, AL).
8. Dubos R, Dubos G. 1987. The White Plague. Tuberculosis, Man, and Society. Rutgers Univesity Press, New Brunswick, NJ.
9. Bennett JH. 1854. The Pathology and Treatment of Pulmonary Tuberculosis, p 180. Blanchard and Lea, Philadelphia, PA.
10. Virchow R. 1860. Cellular Pathology as Based upon Physiological and Pathological Histology, 2nd ed. John Churchill, London, United Kingdom (reprinted 1978 by The Classics of Medicine Library, Birmingham, AL).
11. Powell RD. 1876. On Consumption and on Certain Diseases of Lungs and Pleura, chapter 2, p 291. H.K. Lewis, London, United Kingdom.
12. Tyndale J. 1878. The Present Status of the Pathology of Consumption and Tuberculosis. Trow's Printing and Bookbinding Co, New York, NY.
13. Cornil V, Ranvier L. 1880. Pathological histology of the respiratory apparatus, part III, section I, chapter II, p 394-445. In A Manual of Pathological Histology, Translated with Notes and Additions by EO Shakespeare and JHC Simms. Henry C Lea, Philadephia, PA.
14. Hamilton JD. 1883. On the Pathology of Bronchitis, Catarrhal Pneumonia. Tubercle and Allied Lesions of the Human Lung. Macmillan and Co, London, United Kingdom.
15. Hektoen L, Reisman D. 1901. A Text-Book of Pathology for the Use of Students and Practitoners of Medicine and Surgery, vol 2. W.B. Saunders & Company, London, United Kingdom.
16. Osler W, McCrae T. 1921. The Principles and Practice of Medicine, p 184-255. D. Appleton and Company, New York, NY.
17. Opie E, Aronson J. 1927. Tubercle bacilli in latent tuberculous lesions and in lung tissue without tuberculous lesions. Arch Pathol Lab Med 4:1-21.
18. Kayne GG, Pagel W, O'Shaughenessy L. 1939. Pulmonary Tuberculosis, Pathology, Diagnosis and Management. Oxford University Press, London, United Kingdom.
19. Rich A. 1951. The factors responsible for the characteristics of tuberculous lesions and symptoms, p 713. In The Pathogenesis of Tuberculosis, 2nd ed. Charles C Thomas, Springfield, IL.
20. Medlar EM. 1950. Pathogenetic concepts of tuberculosis. Am J Med 9:611-622 http://dx.doi.org/10.1016/0002-9343(50)90211-7.
21. Canetti G. 1955. The Tubercle Bacillus in the Pulmonary Lesion of Man. Histobacteriology and Its Bearing on the Therapy of Pulmonary Tuberculosis, p 226. Springer Publishing, New York, NY.
22. Gunn FD. 1961. Tuberculosis, p 243-263. In Anderson WAD (ed), Pathology, 4th ed. C.V. Mosby Company, St Louis, MO.
23. Pagel W. 1964. The morbid anatomy and histology of tuberculosis: an introduction in simple terms, p 36-63. In Pulmonary Tuberculosis, Bacteriology, Pathology, Diagnosis, Management, Epidemiology and Prevention. Oxford University Press, London, United Kingdom.
24. Aaron L, Saadoun D, Calatroni I, Launay O, Mémain N, Vincent V, Marchal G, Dupont B, Bouchaud O, Valeyre D, Lortholary O. 2004. Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect 10:388-398 http://dx.doi.org/10.1111/j.1469-0691.2004.00758.x.
25. Mustafa T, Leversen NA, Sviland L, Wiker HG. 2014. Differential in vivo expression of mycobacterial antigens in Mycobacterium tuberculosis infected lungs and lymph node tissues. BMC Infect Dis 14:535 http://dx.doi.org/10.1186/1471-2334-14-535.
26. Hunter RL. 2011. On the pathogenesis of post primary tuberculosis: the role of bronchial obstruction in the pathogenesis of cavities. Tuberculosis (Edinb) 91(Suppl 1):S6-S10 http://dx.doi.org/10.1016/j.tube.2011.10.003.
27. Sanders BM, Orme IM, Basaraba RJ. 2008. Immunopathology of tuberculosis. In Kaufmann SHE, Britton WJ (ed), Handbook of Tuberculosis: Immunology and Cell Biology. Wiley-VCH Verlag. Weinheim, Germany.
28. North RJ, Jung YJ. 2004. Immunity to tuberculosis. Annu Rev Immunol 22:599-623 http://dx.doi.org/10.1146/annurev.immunol.22.012703.104635.
29. Franzblau SG, DeGroote MA, Cho SH, Andries K, Nuermberger E, Orme IM, Mdluli K, Angulo-Barturen I, Dick T, Dartois V, Lenaerts AJ. 2012 Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis. Tuberculosis (Edinb) 92:453-488 http://dx.doi.org/10.1016/j.tube.2012.07.003.
30. Dannenberg AM Jr, Collins FM. 2001. Progressive pulmonary tuberculosis is not due to increasing numbers of viable bacilli in rabbits, mice and guinea pigs, but is due to a continuous host response to mycobacterial products. Tuberculosis (Edinb) 81:229-242 http://dx.doi.org/10.1054/tube.2001.0287.
31. Molina-Ruiz AM, Requena L. 2015. Foreign body granulomas. Dermatol Clin 33:497-523 http://dx.doi.org/10.1016/j.det.2015.03.014.
32. Medlar EM. 1955. The behavior of pulmonary tuberculous lesions: a pathological study. Am Rev Tuberc 71:1-244.
33. Dannenberg AM Jr. 1991. Delayed-type hypersensitivity and cellmediated immunity in the pathogenesis of tuberculosis. Immunol Today 12:228-233 http://dx.doi.org/10.1016/0167-5699(91)90035-R.
34. Dannenberg AM Jr, Higuchi S. 1979. Chronic inflammation involving cellular hypersensitivity. Chest 75(Suppl):265-266 http://dx.doi.org/10.1378/chest.75.2.265.
35. McMurray DN. 2003. Hematogenous reseeding of the lung in lowdose, aerosol-infected guinea pigs: unique features of the host-pathogen interface in secondary tubercles. Tuberculosis (Edinb) 83:131-134 http://dx.doi.org/10.1016/S1472-9792(02)00079-3.
36. McMurray DN. 2001. Disease model: pulmonary tuberculosis. Trends Mol Med 7:135-137 http://dx.doi.org/10.1016/S1471-4914(00)01901-8.
37. Converse PJ, Dannenberg AM Jr, Shigenaga T, McMurray DN, Phalen SW, Stanford JL, Rook GA, Koru-Sengul T, Abbey H, Estep JE, Pitt ML. 1998. Pulmonary bovine-type tuberculosis in rabbits: bacillary virulence, inhaled dose effects, tuberculin sensitivity, and Mycobacterium vaccae immunotherapy. Clin Diagn Lab Immunol 5:871-881.
38. Dannenberg AM Jr. 2009. Liquefaction and cavity formation in pulmonary TB: a simple method in rabbit skin to test inhibitors. Tuberculosis (Edinb) 89:243-247 http://dx.doi.org/10.1016/j.tube.2009.05.006.
39. Converse PJ, Dannenberg AM Jr, Estep JE, Sugisaki K, Abe Y, Schofield BH, Pitt ML. 1996. Cavitary tuberculosis produced in rabbits by aerosolized virulent tubercle bacilli. Infect Immun 64:4776-4787.
40. Barclay WR, Ebert RH, Le Roy GV, Manthei RW, Roth LJ. 1953. Distribution and excretion of radioactive isoniazid in tuberculous patients. J Am Med Assoc 151:1384-1388.
41. Barclay WR, Ebert RH, Manthei RW, Roth LJ. 1953. Distribution of C14 labeled isoniazid in sensitive and resistant tubercle bacilli and in infected and uninfected tissues in tuberculous patients. Trans Annu Meet Natl Tuberc Assoc 49:192-195.
42. Coleman MT, Chen RY, Lee M, Lin PL, Dodd LE, Maiello P, Via LE, Kim Y, Marriner G, Dartois V, Scanga C, Janssen C, Wang J, Klein E, Cho SN, Barry CE III, Flynn JL. 2014. PET/CT imaging reveals a therapeutic response to oxazolidinones in macaques and humans with tuberculosis. Sci Transl Med 6:265ra167 http://dx.doi.org/10.1126/scitranslmed.3009500.
43. Dartois V. 2014. The path of anti-tuberculosis drugs: from blood to lesions to mycobacterial cells. Nat Rev Microbiol 12:159-167 http://dx.doi.org/10.1038/nrmicro3200.
44. Prideaux B, ElNaggar MS, Zimmerman M, Wiseman JM, Li X, Dartois V. 2015. Mass spectrometry imaging of levofloxacin distribution in TB-infected pulmonary lesions by MALDI-MSI and continuous liquid microjunction surface sampling. Int J Mass Spectrom 377:699-708 http://dx.doi.org/10.1016/j.ijms.2014.08.024.
45. Prideaux B, Via LE, Zimmerman MD, Eum S, Sarathy J, O'Brien P, Chen C, Kaya F, Weiner DM, Chen PY, Song T, Lee M, Shim TS, Cho JS, Kim W, Cho SN, Olivier KN, Barry CE III, Dartois V. 2015. The association between sterilizing activity and drug distribution into tuberculosis lesions. Nat Med 21:1223-1227 http://dx.doi.org/10.1038/nm.3937.
46. Subbian S, Tsenova L, Yang G, O'Brien P, Parsons S, Peixoto B, Taylor L, Fallows D, Kaplan G. 2011. Chronic pulmonary cavitary tuberculosis in rabbits: a failed host immune response. Open Biol 1:110016 http://dx.doi.org/10.1098/rsob.110016.
47. Hunter WA, Cundy T, Rabone D, Hofman PL, Harris M, Regan F, Robinson E, Cutfield WS. 2004. Insulin sensitivity in the offspring of women with type 1 and type 2 diabetes. Diabetes Care 27:1148-1152 http://dx.doi.org/10.2337/diacare.27.5.1148.
48. Klein EE. 1875. The Anatomy of the Lymphatic System. The Lung, vol 2. Smith, Elder and Co., London, United Kingdom.
49. Basaraba RJ, Smith EE, Shanley CA, Orme IM. 2006. Pulmonary lymphatics are primary sites of Mycobacterium tuberculosis infection in guinea pigs infected by aerosol. Infect Immun 74:5397-5401 http://dx.doi.org/10.1128/IAI.00332-06.
50. Rayner EL, Pearson GR, Hall GA, Basaraba RJ, Gleeson F, McIntyre A, Clark S, Williams A, Dennis MJ, Sharpe SA. 2013. Early lesions following aerosol infection of rhesus macaques (Macaca mulatta) with Mycobacterium tuberculosis strain H37RV. J Comp Pathol 149:475-485 http://dx.doi.org/10.1016/j.jcpa.2013.05.005.
51. Klein EE. 1873. Contributions to the normal and pathological anatomy of the lymphatic system of the lungs. Proc R Soc Lond 22:133-145 http://dx.doi.org/10.1098/rspl.1873.0018.
52. Sanderson JB. 1867. Communicability of Tubercle by Innoculation. Report of the Medical Officer of the Privy Council. London, United Kingdom.
53. Basaraba RJ, Dailey DD, McFarland CT, Shanley CA, Smith EE, McMurray DN, Orme IM. 2006. Lymphadenitis as a major element of disease in the guinea pig model of tuberculosis. Tuberculosis (Edinb) 86:386-394 http://dx.doi.org/10.1016/j.tube.2005.11.003.
54. Lee P. 2015. Endobronchial tuberculosis. Indian J Tuberc 62:7-12 http://dx.doi.org/10.1016/j.ijtb.2015.02.002.
55. Peyron P, Vaubourgeix J, Poquet Y, Levillain F, Botanch C, Bardou F, Daffé M, Emile JF, Marchou B, Cardona PJ, de Chastellier C, Altare F. 2008 Foamy macrophages from tuberculous patients' granulomas constitute a nutrient-rich reservoir for M. tuberculosis persistence. PLoS Pathog 4:e1000204 http://dx.doi.org/10.1371/journal.ppat.1000204.
56. Russell DG, Cardona PJ, Kim MJ, Allain S, Altare F. 2009. Foamy macrophages and the progression of the human tuberculosis granuloma. Nat Immunol 10:943-948 http://dx.doi.org/10.1038/ni.1781.
57. Mallat Z. 2014. Macrophages. Arterioscler Thromb Vasc Biol 34: 2509-2519 http://dx.doi.org/10.1161/ATVBAHA.114.304794.
58. Basaraba RJ. 2008. Experimental tuberculosis: the role of comparative pathology in the discovery of improved tuberculosis treatment strategies. Tuberculosis (Edinb) 88(Suppl 1):S35-S47 http://dx.doi.org/10.1016/S1472-9792(08)70035-0.
59. Irwin SM, Driver E, Lyon E, Schrupp C, Ryan G, Gonzalez-Juarrero M, Basaraba RJ, Nuermberger EL, Lenaerts AJ. 2015. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis. Dis Model Mech 8:591-602 http://dx.doi.org/10.1242/dmm.019570.
60. Canetti G. 1956. Dynamic aspects of the pathology and bacteriology of tuberculous lesions. Am Rev Tuberc 74:13-21, discussion, 22-27.
61. Saunders BM. 2008. Immunopathology of tuberculosis, p 245-278. In Kaufmann SHE, Britton WJ (ed), Handbook of Tuberculosis: Immunology and Cell Biology. Wiley-VCH Verlag. Weinheim, Germany.
62. Ryan GJ, Hoff DR, Driver ER, Voskuil MI, Gonzalez-Juarrero M, Basaraba RJ, Crick DC, Spencer JS, Lenaerts AJ. 2010. Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach. PLoS One 5:e11108 http://dx.doi.org/10.1371/journal.pone.0011108.
63. Ryan GJ, Shapiro HM, Lenaerts AJ. 2014. Improving acid-fast fluorescent staining for the detection of mycobacteria using a new nucleic acid staining approach. Tuberculosis (Edinb) 94:511-518 http://dx.doi.org/10.1016/j.tube.2014.07.004.
64. Bozza PT, Melo RCN, Bandeira-Melo C. 2007. Leukocyte lipid bodies regulation and function: contribution to allergy and host defense. Pharmacol Ther 113:30-49 http://dx.doi.org/10.1016/j.pharmthera.2006.06.006.
65. Kipnis A, Basaraba RJ, Turner J, Orme IM. 2003. Increased neutrophil influx but no impairment of protective immunity to tuberculosis in mice lacking the CD44 molecule. J Leukoc Biol 74:992-997 http://dx.doi.org/10.1189/jlb.0603301.
66. Ordway D, Palanisamy G, Henao-Tamayo M, Smith EE, Shanley C, Orme IM, Basaraba RJ. 2007. The cellular immune response to Mycobacterium tuberculosis infection in the guinea pig. J Immunol 179:2532-2541 http://dx.doi.org/10.4049/jimmunol.179.4.2532.
67. Tsai MC, Chakravarty S, Zhu G, Xu J, Tanaka K, Koch C, Tufariello J, Flynn J, Chan J. 2006. Characterization of the tuberculous granuloma in murine and human lungs: cellular composition and relative tissue oxygen tension. Cell Microbiol 8:218-232 http://dx.doi.org/10.1111/j.1462-5822.2005.00612.x.
68. Guo RF, Ward PA. 2002. Mediators and regulation of neutrophil accumulation in inflammatory responses in lung: insights from the IgG immune complex model. Free Radic Biol Med 33:303-310 http://dx.doi.org/10.1016/S0891-5849(02)00823-7.
69. Hu M, Miller EJ, Lin X, Simms HH. 2004. Transmigration across a lung epithelial monolayer delays apoptosis of polymorphonuclear leukocytes. Surgery 135:87-98 http://dx.doi.org/10.1016/S0039-6060(03)00347-7.
70. Zemans RL, Colgan SP, Downey GP. 2009. Transepithelial migration of neutrophils: mechanisms and implications for acute lung injury. Am J Respir Cell Mol Biol 40:519-535 http://dx.doi.org/10.1165/rcmb.2008-0348TR.
71. Hunter RL, Olsen M, Jagannath C, Actor JK. 2006. Trehalose 6,6'-dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am J Pathol 168:1249-1261 http://dx.doi.org/10.2353/ajpath.2006.050848.